[1. Aoki H., Nosho K., Igarashi H., Ito M., Mitsuhashi K., Naito T., Yamamoto E., Tanuma T., Nomura M., Maguchi H, Shinohara T, Suzuki H., Yamamoto H., Shinomura Y. MicroRNA-31 expression in colorectal serrated pathway progression // World Journal of Gastroenterology, 2013; 20(34); 12346-1234910.3748/wjg.v20.i34.12346416182225232271]Search in Google Scholar
[2. Chung S., Dwabe S., Elshimali Y., Sukhija H., Aroh C., Vadgama JV. Identification of Novel Biomarkers for Metastatic Colorectal Cancer Using Angiogenesis- Antibody Array and Intracellular Signaling Array // PLoS ONE, 2015; 10(8): e0134948.doi:10.1371/ journal.pone.013494810.1371/journal.pone.0134948453095326258407]Search in Google Scholar
[3. Coppede F., Lopomo A., Spisni R., Migliore L. Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer // World Journal of Gastroenterology, 2014; 20(4): 943-956]Search in Google Scholar
[4. Edwards M.S., Chadda S. D., Zhao Z., Barber B. L. Sykes D. P. A systematic review of treatment guidelines for metastatic colorectal cancer // Color. Dis., 2012; 14: 31-47]Search in Google Scholar
[5. Gonzalez-Pons M., Cruz-Correa M. Colorectal Cancer Biomarkers: Where Are We Now? // BioMed Research International, 2015: 1-1410.1155/2015/149014446172626106599]Search in Google Scholar
[6. Greene F. L., Sobin L. H. The Staging of Cancer: A Retrospective and Prospective Appraisal // CA Cancer J Clin, 2008; DOI: 10.3322/CA.2008.000110.3322/CA.2008.000118460593]Search in Google Scholar
[7. Kirstein M. M., Lange A., Prenzler A., Manns M. P., Kubicka S., Vogel A. Targeted Therapies in Metastatic Colorectal Cancer: A Systematic Review and Assessment of Currently Available Data // The Oncologist, 2014; 19:1156-1168]Search in Google Scholar
[8. Lei S.L., Zhao H., Yao H. L., Chen Y., Lei Z. D., Liu K. J., Yang Q. Regulatory roles of microRNA708 and microRNA31 in proliferation, apoptosis and invasion of colorectal cancer cells // Oncology Letters, 2014; 8: 1768-1774]Search in Google Scholar
[9. Mazeh H., Mizrahi I., Ilyayev N., Halle D., Brücher LDM B., Bilchik A., Protic M., Daumer M., Stojadinovic A., Avital I., Nissan A. The Diagnostic and Prognostic Role of microRNA in Colorectal Cancer - a Comprehensive review // Journal of Cancer; 2013; 4(3): 281-295. doi: 10.7150/jca.583610.7150/jca.5836358484123459799]Search in Google Scholar
[10. Peng Y., Zhai Z., Li Z., Wang L., Gu J. Role of blood tumor markers in predicting metastasis and local recurrence after curative resection of colon cancer // Int J Clin Exp Med, 2015; 8(1):982-990]Search in Google Scholar
[11. Reimers M. S., Zeestraten E. C.M., Kuppen P. J.K., Liefers G. J., van de Velde C.J.H. Biomarkers in precision therapy in colorectal cancer // Gastroenterology Report 2013; 166-183, doi:10.1093/gastro/got02210.1093/gastro/got022393799724759962]Search in Google Scholar
[12. Ross J. S., Torres-Mora J., Wagle N., Jennings T. A., Jones D. M. Biomarker-Based Prediction of Response to Therapy for Colorectal Cancer // American Society for Clinical Pathology, 2010; 134:478-490]Search in Google Scholar
[13. Schee K., Boye K., Weum Abrahamsen T., Fodstad O., Flatmark K. Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer // 2012; Bio Med Central Cancer 12:50510.1186/1471-2407-12-505351962223121918]Search in Google Scholar
[14. Sun D., Yu F., Ma Y., et al. MicroRNA-31 activates the RAS pathway and functions as an oncogenic MicroRNA in human colorectal cancer by repressing RAS p21 GTPase activating protein 1 (RASA1) // Journal of Biological Chemistry. 2013; 288(13):9508-9518]Search in Google Scholar
[15. Wang J., Huang S., Zhao M., Yang M., Zhong J., Gu Y., Peng H., Che Y., Huang C. Identification of a Circulating MicroRNA Signature for Colorectal Cancer Detection // PLOS ONE, 2014; 9(4) e87451: 1-910.1371/journal.pone.0087451397785424709885]Search in Google Scholar
[16. Xu X. M., Qian J. C., Deng Z. L., Cai Z., Tang T., Wang P., Zhang K. H., Cai J.I.P. Expression of miR-21, miR-31, miR-96 and miR-135b is correlated with the clinical parameters of colorectal cancer // Oncology Letters, 2012; 4: 339-345]Search in Google Scholar